Gene: CILP2
Official Full Name: cartilage intermediate layer protein 2provided by HGNC
Gene Summary: Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23519 | CILP2 Knockout cell line (HCT 116) | Human | CILP2 | 1:2~1:4 | Negative | Online Inquiry |
KO23520 | CILP2 Knockout cell line (HEK293) | Human | CILP2 | 1:3~1:6 | Negative | Online Inquiry |
CILP2 Gene Knockout Cell Lines are advanced biological tools specifically engineered to silence the expression of the cartilage intermediate layer protein 2 (CILP2) gene. This innovative product enables researchers to investigate the physiological roles and molecular mechanisms associated with CILP2 in various biological processes, including cartilage development and inflammatory responses. By utilizing precision gene editing techniques such as CRISPR-Cas9, these cell lines provide a reliable model for studying the gene's impacts on disease states, particularly in osteoarthritis and other degenerative joint disorders.
The key functionality of CILP2 Gene Knockout Cell Lines lies in their ability to provide an active platform for gene function analysis. By knocking out the CILP2 gene, researchers can observe manifold alterations in cellular behavior, signaling pathways, and gene expression profiles. This can unveil potential therapeutic targets, enable drug discovery initiatives, and deepen our understanding of skeletal biology.
The scientific significance of CILP2 knockout models is profound, particularly in translational research and clinical applications. Estas models facilitate the examination of disease mechanisms at a cellular level and pave the way for the development of targeted therapies. They also serve as essential resources for genetic studies and pathophysiology investigations.
What sets CILP2 Gene Knockout Cell Lines apart from alternatives is their high specificity and validated performance, ensuring reproducibility and reliability in experimental outcomes. Our product undergoes rigorous quality control to provide researchers with a robust benchmark for their studies, unlike generic or poorly characterized models that may produce inconsistent results.
For researchers and clinicians delving into the complexities of cartilage-related diseases, CILP2 Gene Knockout Cell Lines offer a unique advantage in elucidating the role of CILP2 in pathology and therapeutic response. These cell lines are crucial for advancing knowledge and developing treatment strategies that could improve patient outcomes.
Our company prides itself on expertise in genetic engineering and biotechnology, providing high-quality biological products backed by extensive research and development. By choosing our CILP2 Gene Knockout Cell Lines, you are investing in reliable tools that drive innovation and contribute to breakthroughs in medical science.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.